# US 2026/0265956 A1 · Systems and methods for transfer of reagents between droplets

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0265956 A1
- Document ID: US20260265956A1
- Status: Published application
- Kind: A1
- Application number: 19/658,124
- Filed: 2026-04-24
- Published: 2026-09-10
- Earliest claimed: 2019-02-12
- Assignees: 10x Genomics, Inc.
- Applicants: 10x Genomics, Inc.
- Inventors: Solongo B. ZIRALDO; Geoffrey McDERMOTT; Shea Thompson LANCE
- Web page: https://patentgrep.com/patent/US20260265956A1

## CPC

- B01L 3/502784: {specially adapted for droplet or plug flow, e.g. digital microfluidics}
- C40B 50/06: Biochemical methods, e.g. using enzymes or whole viable microorganisms
- C12Q 1/6804: Nucleic acid analysis using immunogens (immunoassay G01N33/53)
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C40B 40/06: Libraries containing nucleotides or polynucleotides, or derivatives thereof
- B01L 2200/0673: Handling of plugs of fluid surrounded by immiscible fluid
- B01L 2300/0867: Multiple inlets and one sample wells, e.g. mixing, dilution
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The disclosure provides systems and methods for droplet processing. For example, a method can include providing a first droplet and a second droplet. In some cases, the first droplet may have a first concentration of a reagent and the second droplet may have a second concentration of the reagent. The second droplet may comprise a bead or a biological particle. The method can also include subjecting the first droplet and the second droplet to conditions sufficient to transfer the reagent from the first droplet to the second droplet, thereby decreasing the first concentration in the first droplet and increasing the second concentration in the second droplet.

## Claims

### Claim at position 1

1-20. (canceled)

### Claim 21

A method, comprising:
generating a first emulsion using: (i) a first aqueous fluid comprising a reagent, and (ii) a partitioning fluid comprising a fluorinated oil and a fluorosurfactant comprising a perfluoropolyether (PFPE), wherein the first emulsion comprises a first plurality of droplets dispersed in the partitioning fluid, wherein a first droplet of the first plurality of droplets comprises the reagent at a first concentration;
generating a second emulsion using: (i) a second aqueous fluid comprising a plurality of cells and a plurality of beads, wherein a bead of the plurality of beads comprises a plurality of nucleic acid barcode molecules, and (ii) the partitioning fluid, wherein the second emulsion comprises a second plurality of droplets dispersed in the partitioning fluid, wherein a second droplet of the second plurality of droplets comprises a cell of the plurality of cells and the bead of the plurality of beads, and wherein the reagent is absent from the second droplet or present in the second droplet at a second concentration that is lower than the first concentration;
contacting the first emulsion with the second emulsion; and
transferring the reagent from the first droplet to the second droplet via an aggregate of surfactant molecules comprising the reagent.

### Claim 22 (depends on 21)

The method of claim 21, wherein the first aqueous fluid further comprises an ammonium salt and wherein the reagent is a surfactant.

### Claim 23 (depends on 22)

The method of claim 22, wherein the surfactant is SDS.

### Claim 24 (depends on 23)

The method of claim 23, wherein the method further comprises lysing the cell within the second droplet with the surfactant.

### Claim 25 (depends on 24)

The method of claim 24, wherein the reagent is absent from the second droplet before contacting the first emulsion with the second emulsion.

### Claim 26 (depends on 23)

The method of claim 23, wherein the aggregate of surfactant molecules is a micelle.

### Claim 27 (depends on 23)

The method of claim 23, wherein the aggregate of surfactant molecules comprises the fluorosurfactant.

### Claim 28 (depends on 21)

The method of claim 21, wherein the fluorosurfactant comprises a carboxylic acid-terminated PFPE.

### Claim 29 (depends on 28)

The method of claim 28, wherein the fluorosurfactant is a first fluorosurfactant and the partitioning fluid further comprises a second fluorosurfactant.

### Claim 30 (depends on 29)

The method of claim 29, wherein the second fluorosurfactant is a polyethylene glycol (PEG)-PFPE block copolymer.

### Claim 31 (depends on 30)

The method of claim 30, wherein the second fluorosurfactant is a PFPE-PEG-PFPE triblock copolymer.

### Claim 32 (depends on 23)

The method of claim 23, wherein generating the first emulsion comprises combining and agitating the first aqueous fluid and the partitioning fluid.

### Claim 33 (depends on 32)

The method of claim 32, wherein generating the second emulsion comprises combining and agitating the second aqueous fluid and the partitioning fluid.

### Claim 34 (depends on 24)

The method of claim 24, wherein the method further comprises:
hybridizing a nucleic acid barcode molecule of the plurality of nucleic acid barcode molecules to a messenger ribonucleic acid (mRNA) of the cell within the second droplet; and
extending the nucleic acid barcode molecule in a reverse transcription reaction using the mRNA as template to generate a barcoded nucleic acid molecule.

### Claim 35 (depends on 34)

The method of claim 34, wherein the nucleic acid barcode molecule of the plurality of nucleic acid barcode molecules comprises a bead-specific barcode sequence, and wherein the barcoded nucleic acid molecule comprises the bead-specific barcode sequence or a complement thereof and a sequence of the mRNA or a complement thereof.

### Claim 36 (depends on 35)

The method of claim 35, wherein the method further comprises sequencing the barcoded nucleic acid molecule or a derivative thereof.

### Claim 37 (depends on 21)

The method of claim 21, wherein the first aqueous fluid further comprises n-dodecyl-beta-D-maltoside (DBDM), sodium lauroyl sarcosinate, t-Octylphenoxypolyethoxyethanol, or polysorbate 20.

### Claim 38 (depends on 21)

The method of claim 21, wherein:
the first aqueous fluid further comprises an ammonium salt;
the reagent is sodium dodecyl sulfate (SDS);
the fluorosurfactant is a first fluorosurfactant and the partitioning fluid further comprises a second fluorosurfactant;
the first fluorosurfactant comprises a carboxylic acid-terminated PFPE;
the second fluorosurfactant is a polyethylene glycol (PEG)-PFPE block copolymer;
the aggregate of surfactant molecules is a micelle; and
the reagent is absent from the second droplet before contacting the first emulsion with the second emulsion.

### Claim 39 (depends on 38)

The method of claim 38, wherein the second fluorosurfactant is a PFPE-PEG-PFPE triblock copolymer.

### Claim 40 (depends on 39)

The method of claim 39, wherein the method further comprises lysing the cell within the second droplet with the reagent.
